Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 365.43B, Merck(MRK) trades at $148.12. The stock has a price-to-earnings ratio of 114.80 and currently yields dividends of 2.37%.
On 2026-10-20, Merck(MRK) stock traded between a low of $144.66 and a high of $149.36. Shares are currently priced at $148.12, which is +2.4% above the low and -0.8% below the high.
Merck(MRK) shares are trading with a volume of 3.06M, against a daily average of 9.39M.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
MRK News
Merck & Co Inc. (NYSE:MRK) is permanently discontinuing its bacterial infection therapy Zinplava (bezlotoxumab) for commercial reasons. European Regulators Rev...
Merck (NYSE:MRK) plans to invest US$2.9b to expand research and manufacturing operations in Montgomery County, Pennsylvania. The multi year build out focuses o...
Merck (MRK Quick QuoteMRK - Free Report) closed the most recent trading day at $143.63, moving -1.59% from the previous trading session. This change lagge...
Analyst ratings
68%
of 31 ratingsMore MRK News
The German life-sciences and chemicals group said drug divesiran is ready to enter late-stage clinical trials. ralph orlowski / Reuters Germany’s Merck MRK -1....
Goldman Sachs lowered the firm’s price target on Merck (MRK) to $155 from $160 and keeps a Buy rating on the shares. Heading into Q3 results, Merck has continue...
Merck announced that Paul J. Diaz, a healthcare investor and former CEO of Myriad Genetics and Kindred Healthcare, joined its board in November 2026. At the sam...
Investing Bristol Myers Squibb’s 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know Bristol Myers Squibb has raised its dividend for 17 straight y...
Merck (MRK) is back in focus after the company said Paul J. Diaz will join its board on November 1, 2026. The appointment adds deep health care and investment e...
Biopharma stocks like AbbVie and Eli Lilly are trading at or near all-time highs, in the latest signal that investors are seeking out the steady gains that come...
Investing AMGN vs. MRK: Which Pharma Giant’s Dividend Actually Has Room to Grow Amgen and Merck both yield around 2.3% and have surged this year, but one of the...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.